|
SRP68 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69808611616418E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.12999995419239E-09 |
| Normal-vs-Stage2 |
1.086470E-02 |
| Normal-vs-Stage3 |
5.961600E-04 |
| Normal-vs-Stage4 |
1.276800E-03 |
| Stage1-vs-Stage2 |
4.341000E-01 |
| Stage1-vs-Stage3 |
8.967600E-01 |
| Stage1-vs-Stage4 |
4.097800E-01 |
| Stage2-vs-Stage3 |
4.885800E-01 |
| Stage2-vs-Stage4 |
9.984500E-02 |
| Stage3-vs-Stage4 |
3.083600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73783210044576E-12 |
| Normal-vs-AfricanAmerican |
6.11120000000298E-05 |
| Normal-vs-Asian |
1.641370E-01 |
| Caucasian-vs-AfricanAmerican |
4.380700E-03 |
| Caucasian-vs-Asian |
6.271600E-01 |
| AfricanAmerican-vs-Asian |
6.994800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.38630226689907E-11 |
| Normal-vs-Female |
6.25509999352403E-09 |
| Male-vs-Female |
7.282100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.556030E-03 |
| Normal-vs-Extreme_Weight |
1.18420000028152E-07 |
| Normal-vs-Obese |
1.62329999997546E-07 |
| Normal-vs-Extreme_Obese |
1.207950E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.504800E-01 |
| Normal_Weight-vs-Obese |
9.112800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.468600E-01 |
| Extreme_Weight-vs-Obese |
9.273000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.872600E-01 |
| Obese-vs-Extreme_Obese |
3.444000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.83660000000674E-05 |
| Normal-vs-Age(41-60Yrs) |
2.06834549487667E-12 |
| Normal-vs-Age(61-80Yrs) |
4.32050000220841E-08 |
| Normal-vs-Age(81-100Yrs) |
8.558000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.931400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.342200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.221720E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.095000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.583600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.345900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.13082892944294E-14 |
| Normal-VS-Type2 PRCC |
6.619200E-04 |
| Normal-VS-KIRP CIMP |
2.633900E-02 |
| Normal-VS-Unclassified PRCC |
1.764950E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.463500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.779000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.699200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.530200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.910220E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.165000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.999900E-04 |
| Normal-vs-N1 |
6.801400E-04 |
| Normal-vs-N2 |
6.858100E-02 |
| N0-vs-N1 |
2.570400E-01 |
| N0-vs-N2 |
6.379600E-02 |
| N1-vs-N2 |
2.496400E-01 |
|
|
